中远海科(002401) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was CNY 474,303,428.57, a decrease of 0.57% compared to CNY 477,031,198.92 in the same period last year[15]. - Net profit attributable to shareholders for Q3 2023 was CNY 72,711,552.79, an increase of 29.83% from CNY 55,944,052.29 in the previous year[15]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 72,187,504.45, up 41.19% from CNY 51,065,267.16 in the same period last year[15]. - The net profit for the third quarter of 2023 is 184,933,845.57, an increase from 161,899,235.80 in the same period last year, representing a growth of approximately 14.5%[32]. - The operating profit for the third quarter is 205,626,614.24, compared to 184,610,388.25 in the previous year, indicating an increase of about 11.5%[32]. - The total profit for the third quarter is 205,133,614.60, up from 183,611,388.25, reflecting a growth of approximately 11.7%[32]. - Total operating revenue for the current period reached ¥1,337,252,567.14, a slight increase from ¥1,324,515,170.33 in the previous period, representing a growth of approximately 1.4%[48]. - Total operating costs decreased to ¥1,149,269,815.28 from ¥1,158,930,865.37, reflecting a reduction of about 0.8%[48]. - Basic earnings per share improved to ¥0.5009 from ¥0.4406, indicating a growth of about 13.5%[49]. - Total comprehensive income for the current period was ¥184,933,845.57, up from ¥161,899,235.80, which is an increase of approximately 14.2%[51]. Assets and Liabilities - The company's total assets as of the report date were CNY 2,732,880,035.60, a decrease of 12.81% from CNY 3,133,124,181.67 at the end of the previous year[5]. - The total liabilities decreased to 1,081,941,695.34 from 1,637,640,920.13, indicating a reduction in financial obligations[47]. - The total liabilities decreased to ¥1,139,679,065.57 from ¥1,695,386,951.14, a reduction of about 32.8%[48]. - The equity attributable to shareholders increased to CNY 1,593,200,970.03, reflecting a growth of 10.72% from CNY 1,437,737,230.53 at the end of the previous year[5]. - The total equity attributable to shareholders increased to ¥1,593,200,970.03 from ¥1,438,929,969.32, reflecting a growth of approximately 10.7%[48]. Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 149,495,110.03, worsening by 26.42% compared to a net outflow of CNY 118,256,670.02 in the previous year[15]. - The net cash flow from investing activities was -21,492,133.76, a significant decrease compared to -2,185,369.24 from the previous period, indicating increased investment outflows[36]. - The company reported a net cash decrease of 215,887,221.60, compared to a decrease of 166,542,031.19 in the previous year[36]. - The total cash and cash equivalents at the end of the period amounted to 1,421,983,126.02, down from 1,426,585,862.01 in the previous year[36]. - Net cash flow from operating activities was negative at ¥-149,495,110.03, worsening from ¥-118,256,670.02 in the previous period[51]. Accounts and Inventory - Accounts receivable increased by CNY 56,762,700, representing a growth of 167.43% compared to the previous year-end[20]. - The balance of accounts receivable increased to 90,665,218.07, up 167.00% from 33,902,522.84 in the previous year[45]. - Inventory at the end of the reporting period decreased by CNY 344,490,800, a decline of 39.65% due to increased inventory turnover[8]. - Contract liabilities decreased by CNY 549,814,300, down 43.54% compared to the previous year-end, mainly due to increased revenue recognition[9]. - The balance of contract assets rose to 81,328,500.63, reflecting a growth of 235.07% compared to 24,272,072.46 last year[41]. - The balance of other current assets increased to 7,741,000.33, a significant rise of 522.64% from 1,243,258.16 in the previous year[41]. - The balance of other payables increased to 85,324,853.24, a growth of 120.70% compared to 38,660,326.12 last year[42]. Research and Development - Research and development expenses increased by 1,701.71 million, a growth of 66.04% compared to the same period last year[42]. - Research and development expenses increased significantly to ¥42,786,630.20 from ¥25,769,549.01, marking a rise of approximately 66%[48]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 49,763[24]. - The largest shareholder, Shanghai Shipbuilding Transport Scientific Research Institute Co., Ltd., holds 48.93% of shares, totaling 181,984,400 shares[24]. Strategic Focus - The company is focusing on expanding its market presence and enhancing its product offerings through new technology developments[33]. - The company has plans for strategic acquisitions to bolster its competitive position in the industry[33]. - The company aims to improve shareholder value through effective management of its assets and investments[33].